📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease. (2016)

First Author: Smolen JS

Attributed to: Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2016-209429

PubMed Identifier: 27037326

Publication URI: http://europepmc.org/abstract/MED/27037326

Type: Journal Article/Review

Volume: 75

Parent Publication: Annals of the rheumatic diseases

Issue: 7

ISSN: 0003-4967